Biography

Prof. Mary Geitona

University of Peloponnese, Greece


Email: marygeitona@gmail.com


Qualifications

1992 Ph.D., University of Athens, Greece, Health Economics

1990 M.S., University of Athens, Greece, Research Methodology

1988 B.S., National School of Public Health, Greece, Health Services Management


Publications (Selected)

  1. Zisis, K., Pavi, E., Geitona, M., & Athanasakis, K. (2024). Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process. Journal of Pharmacy & Pharmaceutical Sciences, 27, 12302.
  2. Giannake, G., Economou, A., Metaxas, T., & Geitona, M. (2023). Medical tourism in the Region of Thessaly, Greece: Opinions and perspectives from healthcare providers. Sustainability, 15(10), 7864.
  3. Latsou, D., Bolosi, F. M., Androutsou, L., & Geitona, M. (2022). Professional quality of life and occupational stress in healthcare professionals during the COVID-19 pandemic in Greece. Health Services Insights, 15, 11786329221096042.
  4. Latsou D., & Geitona M. (2020)Predictors of physical and mental health among unemployed people in Greece. Journal of Health and Social Sciences, 5,1:115-126.
  5. GeitonaΜ., StamuliΕ., Giannakodimos S., Kimiskidis V., Kountouris V., CharokopouΜ., Christou P. (2019) Lacosamide as firtst line treatment option in focal epilepsy; a cost-utility analysis for the Greek healthcare system. Journal of Medical Economics,doi.org/10.1080/13696998.2019.1571499.
  6. Latsou D. Geitona M. (2018) Unemployment effects on health status and risk behaviors in times of economic crisis: the European and Greek evidence. In M. Saridi and K.Souliotis (Eds)The Impact and Implications of Crisis: A Comprehensive Approach Combining Elements of Health and Society.NovaScience Publisher, N. York,,Chapter 9:145-169.
  7. Latsou D., Geitona M. (2018) The effects of unemployment and economic distress on Dipression Symptoms. Mater Sociomed, 30(3): 180-184.
  8. Kamusheva M., Manova M., Savova A., Petrova G. et al (2018)Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries. Frontiers in Pharmacology, vol. 9, https://www.frontiersin.org/articles/10.3389/fphar.2018.00795/full.
  9. Geitona Μ., Latsou D., Toska A., Saridi M. (2018) Polypharmacy and adherence among diabetic patients in Greece: a cross-sectional study. Consult Pharm, 33 (10):562-571.
  10. Saridi M,Toska A,Latsou D, Tsourapa T., Geitona M. (2018) Traumas’ management in a primary health care level.International Journal of Caring Sciences, 2(11): 927-934.
  11. Stafyla E., Geitona M., Kerenidi T., Economou A., Daniil Z., Gourgoulianis K. (2018)The annual direct costs of stable COPD in Greece. International Journal of COPD, (13):309–315.
  12. Saridi M., Kapogeorgou H., Rekleiti M., Geitona M., Souliotis K. (2017)Knowledge andattitudes of women regarding gynecological cancer prevention in an urban areaof Greece in financial crisis.Scand J Caring Sci, 31(4): 710-717.
  13. Stafyla E., Kerenidi T., Gerogianni I., Geitona M., Daniil Z., Gourgoulianis K. (2017) The pharmacological cost of COPD during Greek economic crisis.Int J Chron Obstruct Pulmon Dis., 12: 461-466.
  14. Geitona M.,ToskaA.,Latsou D.,SaridiM., Evripidou A., Evripidou I. (2017).Antibiotics' Prescribing and Pharmacovigilance Attitudes among Pediatricians and Pediatric Residents in Cyprus. Pharmacology and Pharmacy, 8, 75-84.
  15. Toska A, Saridi M, Latsou D, Geitona M. (2017) Antimicrobial Drugs. InBerhardtV.L (Eds)Advances in Medicine and biology(vol.124). Nova Science Publisher, N. York, Chapter 1: 1-27.
  16. Toska A,Saridi M,Apostolopoulou E, Geitona M. (2017) Antibiotic Use and Antimicrobial Resistance.  InBerhardtV.L (Eds)Advances in Medicine and biology(vol.124). Nova Science Publisher, N. York, Chapter 2: 29-53.
  17. Toska A,Saridi M,Mouskou S, Geitona M. (2017) Imprudent Antibiotic Prescribing and Antibiotic Use in Pediatrics. InBerhardtV.L (Eds)Advances in Medicine and biology(vol.124). Nova Science Publisher,N. York, Chapter 3: 56-82.
  18. Saridi M,Toska A, Souliotis K, Geitona M. (2017)General and Pediatric Pharmacovigilance. InBerhardtV.L (Eds)Advances in Medicine and biology(vol.124). Nova Science Publisher,N. York, Chapter 4: 83-100.
  19. Milioni, S.O. & Geitona, M. (2017). The Impact of Incarceration on Greek Female Prisoners’ Self-reported Health Status.J Women's Health Care, 6: 386.
  20. GeitonaM.,KousoulakouH.,GoulisI,ManolakopoulosS.,VasiliadisTh.,ChristodoulouD.,GogosCh.,DourakisS.,KoskinasI.G.,Alexandra PapadokostopoulouA.,LathourisA.,PapatheodoridisG. (2017)Managing Hepatitis C patients in Greece: a budget impact analysis of simeprevir plus pegylated interferon/ribavirin regimen at early stages of the disease.Health,9 (11):1482-1492
  21. Geitona M., Kousoulakou H., Boukovina I., Georgoulias V., Kosmidis P., Koumakis G., Krikelis D., Markouri A., Makrantonakis P., Samantas E. Syrigos K. (2016)Treatment Pathways and Associated Costs of Advanced or Metastatic ALK-Positive Non-Small Cell Lung Cancer in Greece. Pharmacoeconomics,1:2, DOI: 10.4172/2472-1042.1000109.
  22. Geitona M., Milioni S.O. (2016) Female Prisoners’ Views and Satisfaction on Incarceration Conditions: Findings of a Cross-Sectional Survey in Greece, J Psychol Psychother,6:5.
  23. Geitona M., Milioni S.O. (2016) Health Status and Access to Health Services of Female Prisoners in Greece: a cross-sectional survey.BMC Health Services Research 16:243 DOI 10.1186/s12913-016-1506.


Profile Details

https://scholar.google.com/citations?user=FUC4284AAAAJ&hl=en&oi=ao
https://www.researchgate.net/profile/Mary-Geitona
https://sciprofiles.com/profile/author/YWMwa3FSdGZ1cExvUXBoZ1FLWnJCQT09

Free SCIRP Newsletters
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top